Mutating chikungunya virus non‐structural protein produces potent live‐attenuated vaccine candidate

Currently, there are no commercially available live‐attenuated vaccines against chikungunya virus (CHIKV). Here, CHIKVs with mutations in non‐structural proteins (nsPs) were investigated for their suitability as attenuated CHIKV vaccines. R532H mutation in nsP1 caused reduced infectivity in mouse ta...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:EMBO Mol Med
Hauptverfasser: Chan, Yi‐Hao, Teo, Teck‐Hui, Utt, Age, Tan, Jeslin JL, Amrun, Siti Naqiah, Abu Bakar, Farhana, Yee, Wearn‐Xin, Becht, Etienne, Lee, Cheryl Yi‐Pin, Lee, Bernett, Rajarethinam, Ravisankar, Newell, Evan, Merits, Andres, Carissimo, Guillaume, Lum, Fok‐Moon, Ng, Lisa FP
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2019
Schlagworte:
Research Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6554673/
https://ncbi.nlm.nih.gov/pubmed/31015278
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201810092
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge